Ocugen, Inc. (OCGN) Corporate Subsidiaries
Ocugen, Inc. (OCGN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OCGN
CIK: 1372299
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerChristopher Hudson
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | FORM 8-K | 0001104659-26-115970 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-13 | FORM 8-K | 0001104659-26-115921 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-09 | FORM 4 | 0001628280-26-065797 | View SEC Doc Filr Page |
| 144 | 2026-10-09 | — | 144 Filing | 0001628280-26-065563 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-05 | 8-K | 0001628280-26-065077 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-21 | 8-K | 0001628280-26-063084 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | FORM 4 | 0001628280-26-061626 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001628280-26-061150 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-01 | FORM 8-K | 0001104659-26-105968 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-14 | — | DEFA14A | 0001104659-26-096110 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000196 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000513 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054057 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-091691 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-30 | — | DEFA 14A | 0001140361-26-030261 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-30 | 2026-09-21 | DEF 14A | 0001140361-26-030258 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002838 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-20 | 2026-09-21 | PRE 14A | 0001140361-26-028979 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | FORM 8-K | 0001104659-26-082897 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001628280-26-043886 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-074078 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-074076 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-074073 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-074072 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-074064 | View SEC Doc Filr Page |